Vanguard Group Inc Ptc Therapeutics, Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PTCT
# of Institutions
198Shares Held
83.7MCall Options Held
192KPut Options Held
129K-
Wellington Management Group LLP Boston, MA8.9MShares$272 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.57MShares$231 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.42MShares$227 Million3.47% of portfolio
-
Armistice Capital, LLC New York, NY6.76MShares$207 Million2.68% of portfolio
-
State Street Corp Boston, MA4.11MShares$126 Million0.01% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $2.19B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...